The subject of the contract is the supply of oncological drugs, supporting drugs and auxiliary equipment

1) Cisplatinum concentrate for solution for infusion, 1 mg/ml vial. 50 ml - 50 vials;

2) Cisplatinum concentrate for solution for infusion, 1 mg/ml vial 100ml - 500 vials.

1) Dacarbazine 100mg - 100 fiol.;

2) Dacarbazine 200mg - 100 fiol.;

3) Dacarbazine 500mg - 100 fiol.

1) Dexamethasone phosphate 4mg/ml (op. 5amp.) - 150 op.

1) Nivolumab 40mg/4ml - 700 pcs.;

2) Nivolumab 100mg/10ml - 1400 pcs.

1) Cabozantynib 20mg (op. 30szt.) - 30 op.;

2) Cabozantynib 40mg (op. 30szt.) - 40 op.;

3) Cabozantynib 60mg (op. 30szt.) - 60 op.

1) Anagrelidum 0.5mg (op. 100 szt.) - 150 op.

1) Trastuzumab 150mg -150 pcs.;

2) Trastuzumab 420mg - 150 pcs.

1) Ibrutynib 140mg (op. 30 szt.) - 24 op.;

2) Ibrutynib 280mg (op. 30 szt.) - 24 op.;

3) Ibrutynib 420mg (op. 30 szt.) - 50 op.

1) Pembrolizumab 100mg - 400 pcs.

1) Ozymertynib 40mg (op. 30szt.) - 5 op.;

2) Ozymertynib 80mg (op. 30szt.) - 50 op.

1) Atezolizumab 1200mg/20ml - 80 pcs.

1) Pixantrone 29mg - 20 pcs.

1) Vinblastine sulfate 10mg z rozpuszczal. - 60 fiol.

1) Pomalidomid 1mg (op. 21szt.) - 2 op.;

2) Pomalidomid 2mg (op. 21szt.) - 4 op.;

3) Pomalidomid 3mg (op. 21szt.) - 10 op.;

4) Pomalidomid 4mg (op. 21szt.) - 10 op.

1) Trastuzumab emtunsine 100mg - 300 pcs.;

2) Trastuzumab emtunsine 160mg - 100 pcs.

1) Encorafenib 75 mg x 42 pcs. - 15 op.;

2) Encorafenib 50 mg x 28 pcs. - 5 op.;

3) Binimetinib 15 mg x 84 pcs. - 15 op.

1) Nintedanibum 150mg (op. 60 szt.) - 10 op.;

2) Nintedanibum 100mg (op. 120 szt.) - 10 op.

1) Afatynib 20mg (op. 28 szt.) - 6 op.;

2) Afatynib 30mg (op. 28 szt.) - 18 op.;

3) Afatynib 40mg (op. 28 szt.) - 18 op.

1) Venetoclaxum 10 mg tabl. powl. (Op.14 szt.) - 5 on.;

2) Venetoclaxum 50 mg tabl.powl. ( op. 7szt.) - 5 on.;

3) Venetoclaxum 100 mg tabl. powl. ( op. 7 szt.) - 5 on.;

4) Venetoclaxum 100 mg tabl. powl. (Op. 14 szt.) - 5 on.;

5) Venetoclaxum 100 mg tabl. powl. (op.112 szt.) - 60 on.

1) Daratumumab 1800mg/15ml - 100 pcs.

1) Aflibercept 100mg/4ml vial. - 10 pcs.;

2) Aflibercept 200mg/8ml vial. - 10 pcs.

1) Carfilzomib 10 mg vial. - 30 pcs.;

2) Carfilzomib 60 mg vial. - 30 pcs.

1) Tipiracilum 6.14 mg + trifluridinum 15 mg tabl. powl. (op.20 szt.) - 15 op.;

2) Tipiracilum 6.14 mg + trifluridinum 15 mg tabl. powl. (op.60 szt.) - 30 on.;

3) Tipiracilum 8.19 mg + trifluridinum 20 mg tabl. powl. (op.20 szt.) - 15 op.;

4) Tipiracilum 8.19 mg + trifluridinum 20 mg tabl. powl. (op.60 szt.) - 40 on.

1) Vincristine sulfate 1mg gotowy koncentrat - 180 fiol.

1) Trastuzumab 150mg - 150 pcs.;

2) Trastuzumab 420mg - 150 pcs.

1) Rituximabum concentrate for solution for infusion, 100 mg - 300 pcs.;

2) Rituximabum concentrate for solution for infusion, 500 mg - 200 pcs.

1) Pegfilgrastimum solution for injection, 6mg/0.6ml - 350 pcs.

1) Azacitidinum, powder for suspension for injection or concentrate 100mg vial. - 250 pcs.

1) Isatuximabum 500mg - 60 pcs.;

2) Isatuximabum 100mg - 100 pcs.

1) Closed system with needle-free port for bag pick-up with contoured finger grip. On the one hand, the device ends with a spike with wings for easy insertion into the bag and an additional needle-free port with a silicone, self-closing, flat membrane, on the other hand, a port compatible with any infusion set, secured with a tethered plug. Can be used for up to 600 activations. The instrument is adapted for repeated contact with blood, lipids, chemotherapeutics, chlorhexidine and alcohols. Free of latex, DEHP and metal parts - 500 pcs.;

2) A device that allows the addition of a drug solution to an infusion fluid bag. Used to administer the drug directly into the infusion fluid bag through a compatible connection with the syringe transfer device. The device allows the connection of a standard infusion set, sterile, packed separately (individually) - 500 pcs.;

3) Vial adapter for drug dissolution and pressure equalization in a closed system. For vials with a diameter of 20 mm. A closed system that allows the lyophilized drug to be reconstituted and the solution to be withdrawn from the vial into the syringe. It has a longitudinally cut plastic needle for maximum withdrawal of the drug from the vial, a double elastomeric membrane for dry joints, and an expanding outer chamber with a volume of 20 ml. It protects against leakage and release of aerosols, fumes of hazardous substances. PVC-free. It has the ONB code assigned by the FDA - 600 pcs.;

4) Needle-free device for safe transfer of medication in a syringe with luer lock tip. A device (connector) that allows a cytostatic (cytotoxic) drug solution to be withdrawn from a vial, safely transferred in a syringe and added to an infusion fluid container or intravenous puncture site, creating a closed, sealed system with elastomeric membranes to keep the connections dry. PVC-free. The device has a mechanism that prevents it from being unscrewed from the syringe again - 400 pcs.;

5) A universal needle-free instrument for the preparation and withdrawal of solutions from vials of different neck diameters, allowing multiple aseptic withdrawal from a micro spike collection container. It has a venting mechanism with a 0.2 micron bacterial hydrophobic filter to equalize the pressure in the vial when the solvent is added to the vial and when the drug solution is withdrawn from the vial, as well as to eliminate the formation of aerosol of the drug solution. Designed to easily and effectively disinfect the flat contact surface of the syringe junction, easy and effective removal of withdrawal solution residue from the junction-syringe interface when the syringe is unscrewed, and prevents the contents of the vial from flowing back when the syringe is unscrewed from the connector, even in the event of overpressure in the vial. The filter along the entire length of the gripping part of the device, not protruding beyond the cross-section and longitudinal section of the body of the device, which allows ergonomic work with the device. Duration of application up to 7 days or 140 activations, whichever comes first, while maintaining the rules of proper disinfection. The filling volume of the whole system is 0.28ml. A micro spike, i.e. a spike longitudinally cut to the middle of its length, with a trough that allows maximum withdrawal of the drug from the vial, without loss. A spike with two oppositely placed holes, one at the top of the spike, the other halfway down its length. Latex-free design for the drug to prevent contact with PVC and aluminum, 1000 pcs.

1) Bleomycin hydrochloride 15mg - 100 fiol.

1) Mitomycin 10mg - 30 fiol.

1) Palbociclib 75mg kaps. (Op. 21szt.) - 15 op.;

2) Palbociclib 100mg kaps. (Op. 21szt.) - 15 op.;

3) Palbociclib 125mg kaps. (Op. 21szt.) - 36 on.

1) Cyclophosphamide 1g - 400 fiol.;

2) Cyclophosphamide 200mg - 300 fiol.

1)Cyclophosphamide 50mg drażetki (op. 50 szt.) - 20 op.

1) Melphalan 2mg tablets (pack of 25) - 30 packs.

1) Chlorambucil 2mg tablets (pack of 25) - 30 pack.

1) Doxorubicini hydrochloridum concentrate for solution for infusion, 2 mg/ml, vial. 5 ml - 100 vials;

2) Doxorubicini hydrochloridum concentrate for solution for infusion, 2 mg/ml, vial. 25 ml - 250 vials;

3) Doxorubicini hydrochloridum concentrate for solution for infusion, 2 mg/ml, vial. 50 ml - 250 vials

1) Etoposidum - concentrate for solution for infusion 100mg - 150 vials;

2) Etoposidum - concentrate for solution for infusion 200mg - 300 vials.

1) Fluorouracilum solution for injection and infusion, 5000 mg - 900 vials;

2) Fluorouracillum solution for injection and infusion, 1000 mg - 50 vials.

1) Bicalutamide 50mg tablets (pack of 28) - 8 packs.

1) Ondansetron hydrochloride 8mg (op. 5 ampułek) - 1500 op.

1) Aprepitant 80mg 2 caps.+125mg 1 caps. - 80 op.

1) Filgrastim 30 million U prefilled syringe. - 100 pcs.;

2) Filgrastim 48 million U prefilled syringe. - 150 pcs.

1) Vemurafenib 240mg tabl. (Op. 56 szt.) - 12 on.

1) Cobimetinib 20mg tabl. (Op. 63 szt.) - 6 on.

1) Gemcitabinum concentrate for solution for infusion 2000mg - 350 vials;

2) Gemcitabinum concentrate for solution for infusion 1000mg - 250 vials;

3) Gemcitabinum concentrate for solution for infusion 200mg - 100 vials.

1) Calcium folinate roztw. 500Mg - 200 fiol.;

2) Calcium folinate roztw. 1000Mg - 500 fiol.

1) Ifosfamide 1g - 200 fiol.;

2) Ifosfamide 2g - 200 fiol.

1) Paclitaxel roztw. 300Mg - 900 fiol.

1) Ribociclib 200mg x 63 tabl. - 140 on.

1) Darbepoetin alpha 500mcg - 100 st.

1) Trastuzumab 600mg/5ml do podania podskórnego - 380 fiol.

1) Topotecan concentrate solution 4mg - 50 vials;

2) Topotecan concentrate solution 1mg - 50 vials.

1) Temozolomidum capsules 5, 20, 100, 140, 180, 250mg - 100000mg

1) Capecitabine 150mg tablets (60 pcs.) - 100 packs;

2) Capecitabine 500mg tablets (pack of 120) - 500 pack.

1) Cladribine roztw. 10mg - 20 fiol.

1) Epirubicin – ready-made concentrate for preparations. Development. 10mg - 60 vials;

2) Epirubicin – a ready-made concentrate for preparations. Development. 50mg - 50 vials.

1) Fedratinibum 100 mg x 120 caps. - 24 op.

1) Mesna roztw. 400mg - 900 amp.

1) Irinotecani concentrate for solution for infusion 300mg - 500 vials;

2) Irinotecani concentrate for solution for infusion 100mg - 500 vials;

3) Irinotecani concentrate for solution for infusion 40mg - 50 vials.

1) Cytarabine roztw. 100mg - 20 fiol.;

2) Cytarabine roztw. 500mg - 20 fiol.;

3) Cytarabine roztw. 1000mg - 80 fiol.

1) Fulvestran 500mg (2 pre-filled syringes of 250mg) - 250 packs.

1) Oxaliplatinum – concentrate for solution for infusion 50mg - 300 vials;

2) Oxaliplatinum concentrate for solution for infusion 100mg - 400 vials;

3) Oxaliplatin - concentrate for solution for infusion 200mg - 500 vials.

1) Doxorubicinum pegylated liposomal, concentrate for solution for infusion, 2 mg/ml, vial. 10 ml - 150 vials

1) Ixazomib 4 mg x 3 caps. - 40 op.;

2) Ixazomib 3 mg x 3 caps. - 20 op.;

3) Ixazomib 2.3 mg x 3 caps. - 20 op.

1) Vinorelbine capsules 20mg - 450 pcs.;

2) Vinorelbine capsules 30mg - 600 pcs.

1) Bortezomib 3,5mg - 400 fiol.

1) Netupitant 300mg + palonosetron 0.5mg - 100 pcs.

1) Durvalumabum 120 mg / 2.4 ml -40 op.;

2) Durvalumabum 500 mg / 10 ml - 400 op.

1) Vinorelbinum concentrate for solution for infusion, 10 mg/ml, 1ml vial - 60 vials;

2) Vinorelbinum concentrate for solution for infusion, 10 mg/ml vial. 5 ml - 20 vials.

1) Cetuximab roztwór 100mg - 200 fiol.;

2) Cetuximab roztwór 500mg - 300 fiol.

1) Liposomal doxorubicin 50mg powder and ingredients for concentrate (2 comp. ) - 50 pack.

1) Vinorelbine 80 mg - 15 pcs.

1) Imatinib 400mg capsules (30 pcs.) - 80 packs;

2) Imatinib 100mg capsules (60 pcs.) - 10 packs.

1) Sunitinib 12.5mg hard capsules (pack of 28) - 6 packs;

2) Sunitinib 25mg hard capsules (pack of 28) - 6 packs;

3) Sunitinib 50mg hard capsules (pack of 28) - 45 pack.

1) Ipilimumabum 50 mg / 10 ml - 20 violin.;

2) Ipilimumabum 200 mg/40 ml – 20 violin.

1) Sorafenib 200mg tabl. powl. (Op. 112szt.) - 20 on.

1) Lapatynib 250mg tabl. powl. (Op. 140 szt.) - 40 on.

1) Panitumumab 100mg - 100 fiol.;

2) Panitumumab 400mg - 110 fiol.

1) Pemetrexed 100mg - 75 fiol.;

2) Pemetrexed 500mg - 50 fiol.

1) Methotrexate roztwór do wstrzykiwań 10mg/ml,fiol. 5 ml - 70 fiol.

1) Thalidomide 100mg (at 30 szt.) - 100 on.

1) Levofolinic acid 200mg - 500 violin.;

2) Levofolinic acid 450mg - 400 violin.

1) Fluorouracil 500mg - 100 fiol.;

2) Fluorouracil 1000mg - 300 fiol.;

3) Fluorouracil 5000mg - 300 fiol.

1) Darolutamide 300 mg x 112 pcs. - 24 op.

1) Lomustyna kaps. 40mg (op. 10 szt.) - 8 op.

1) Brentuximab vedotin 50mg - 20 pcs.

1)Zoledronic acid fiol. 4mg - 100 szt.

1) Ewerolimus tabl. 5mg (op. 30 szt.) - 15 op.;

2) Ewerolimus tabl. 10mg (op. 30 szt.) - 16 on.

1) Brigatinib 180 mg x 28 pcs. - 12 op.;

2) Brigatinib 90 mg x 28 pcs. - 12 op.;

3) Brigatinib 90 mg x 7 pcs + 180 mg x 21 pcs. - 6 op.

1) Rasburykaza 1.5mg (op. 3 szt.) - 150 op.

1) Methotrexate 2.5mg tablets (50 pcs.) - 10 packs.

1) Bendamustyny chlorowodorek 25mg (op. 5 fiol.) - 25 op.;

2) Bendamustyny chlorowodorek 100mg (op. 5 fiol.) - 25 op.

1) Ruksolitynib 5mg (op. 56szt.) - 20 op.

2) Ruksolitynib 15mg (op. 56szt.) - 20 op.;

3) Ruksolitynib 20mg (op. 56szt.) - 10 op.

1) Lenalidomid 5mg (op. 21szt.) - 30 op.;

2) Lenalidomid 10mg (op. 21szt.) - 20 op.;

3) Lenalidomid 15mg (op. 21szt.) - 50 op.;

4) Lenalidomid 25mg (op. 21szt.) - 200 op.

1) Lanreotidum 120mg/0.5ml amp.-shot - 30 pcs.;

2) Lanreotidum 90mg/0.5ml amp.-shot - 6 pcs.

1) Dexketoprofen 50mg/2ml (op. 5amp.) - 200 on.

1) Paclitaxel transfusion apparatus - 2000 pcs.

1) Niraparib 100 mg x 56pcs. - 30 op.;

2) Niraparib 100 mg x 84pcs. - 20 op.

1) Abiraterone 500mg (op. 60 szt.) - 50 on.

1) Pazopanib 400mg (op. 60 szt.) - 55 op.;

2) Pazopanib 200mg (op. 30 szt.) - 20 op.

1) Azacitidine 100mg - 230 pcs.

1) Carboplatinum - concentrate for solution for infusion 50mg - 400 vials;

2) Carboplatinum - concentrate for solution for infusion 150mg - 400 vials;

3) Carboplatinum - concentrate for solution for infusion 450mg - 250 vials;

4) Carboplatinum - concentrate for solution for infusion 600mg - 230 vials.

1) Procarbazinum 50mg kaps. (Op. 50szt.) - 12 on.

1) Elastomeric pump for the supply of single-use medicines; ensuring a continuous flow of the drug for 135 h with a nominal volume of 270 ml; delivery rate 2 ml/h comfortable oval shape with a soft and durable outer layer, small size; The filling port is closed with a Luer Lock cap and secured with a cap to protect against mechanical damage and contamination. The filling port is integrated with a non-returnable valve to prevent the drug from flowing back into the syringe. An infusion tube with a clamp to stop the infusion and a 1.2 um particle filter with a vent located at the end of the drain, the end of the drain with a luer lock tip, closed with a stopper. Maximum filling volume 295ml. The infusion system must be compatible and stable with cytostatics, e.g. 5-Fluorouracil - 150 pcs.;

2) Pump bag, with the possibility of attaching it to the belt - 150 pcs.;

3) Elastomeric pump for the supply of single-use medicines; ensuring a continuous flow of the drug for 55 h with a nominal volume of 270 ml; delivery rate 5 ml/h comfortable oval shape with a soft and durable outer layer, small size; The filling port is closed with a Luer Lock cap and secured with a cap to protect against mechanical damage and contamination. The filling port is integrated with a non-returnable valve to prevent the drug from flowing back into the syringe. An infusion tube with a clamp to stop the infusion and a 1.2 um particle filter with a vent located at the end of the drain, the end of the drain with a luer lock tip, closed with a stopper. Maximum filling volume 295ml. The infusion system must be compatible and stable with cytostatics, e.g. 5-Fluorouracil - 100 pcs.;

4) Pump bag, with the possibility of attaching it to the belt - 100 pcs.;

5) Elastomeric pump for the supply of single-use medicines; ensuring a continuous flow of the drug for 50 h with a nominal volume of 100 ml; delivery rate 2 ml/h comfortable oval shape with a soft and durable outer layer, small size; The filling port is closed with a Luer Lock cap and secured with a cap to protect against mechanical damage and contamination. The filling port is integrated with a non-returnable valve to prevent the drug from flowing back into the syringe. An infusion tube with a clamp to stop the infusion and a 1.2 um particle filter with a vent located at the end of the drain, the end of the drain with a luer lock tip, closed with a stopper. Maximum filling volume 125ml. The infusion system must be compatible and stable with cytostatics, e.g. 5-Fluorouracil - 150 pcs.;

6) Pump bag, with the possibility of attaching it to the belt - 150 pcs.;

7) Elastomeric pump for the supply of single-use medicines; ensuring a continuous flow of the drug for 25 h with a nominal volume of 100 ml; delivery rate 5 ml/h comfortable oval shape with a soft and durable outer layer, small size; The filling port is closed with a Luer Lock cap and secured with a cap to protect against mechanical damage and contamination. The filling port is integrated with a non-returnable valve to prevent the drug from flowing back into the syringe. An infusion tube with a clamp to stop the infusion and a 1.2 um particle filter with a vent located at the end of the drain, the end of the drain with a luer lock tip, closed with a stopper. Maximum filling volume 125 ml. The infusion system must be compatible and stable with cytostatics, e.g. 5-Fluorouracil - 400 pcs.;

8) Pump bag, with the possibility of attaching it to the belt - 400 pcs.

1) Aksytynib 1mg (op. 56szt.) - 6 op.;

2) Aksytynib 5mg (op. 56szt.) - 6 op.

1) Gefitynib 250mg (op. 30 szt.) - 6 op.

1) Bexaroten 75mg capsules (pack of 100) - 12 packs.

1) Devices for multiple withdrawal from the bottle containing the cytotoxic drug by aseptic technique, demonstrating stability and compatibility with them - 1500 pcs.

1) Crizotinib 250mg hard capsules (pack of 60) - 10 packs;

2) Crizotinib 200mg hard capsules (60 packs) - 6 packs.

1) Apalutamide 60 mg x 120 pcs. - 24 op.

1) Ramucirumabum 10 mg/ml 2 fiol. po 10 ml - 150 op.

1) Temsirolimus 30mg concentrate + solution - 12 pcs.

1) Docetaxelum concentrate for solution for infusion 20mg - 400 vials;

2) Docetaxelum concentrate for solution for infusion 80mg - 500 vials.

1) Dabrafenib 50mg caps. hard (28 pcs.) - 4 packs

2) Dabrafenib 75mg caps. hard (120 pcs.) - 40 pcs.

1) Trametinib 0.5mg tabl. coated (pack of 30) - 4 packs;

2) Trametinib 2mg tabl. coated (pack of 30) - 40 packs

1) Olaparibum 150mg tabl. (Op. 56 szt.) - 80 on.;

2) Olaparibum 100mg tabl. (Op. 56 szt.) - 40 on.

1) Obinutuzumab 1g/40ml concentrate for solution for infusion vial. - 100 pcs.

1) Pertuzumab 420mg/14ml concentrate for solution for infusion vial. - 200 pcs.

1) Paclitaxelum albuminatum powder for suspension for infusion, 100mg vial - 140 pcs.

1) Trabectedin 0.25mg - 35 pcs.;

2) Trabectedin 1mg - 50 pcs.

1) Enzalutamide 40mg kaps. (Op. 112 szt.) - 100 on.

1) Fludarabine phosphate 10mg tabl. powl. (Op. 20 szt.) - 20 on.

1)Alektynib 150mg kaps. (Op. 224 szt.) - 20 on.